4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-010492
Chief Commercial Officer sold 1,834 shares at an average $325.98 ($597,840)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Huntsman Carole Chief Commercial Officer | 2025-03-03 | Sale 10b5-1 | −71 | $313.08 | $22,229 | 10,367 | D |
| Huntsman Carole Chief Commercial Officer | 2025-03-03 | Sale 10b5-1 | −200 | $314.74 | $62,948 | 10,167 | D |
| Huntsman Carole Chief Commercial Officer | 2025-03-03 | Sale 10b5-1 | −300 | $320.21 | $96,063 | 9,867 | D |
| Huntsman Carole Chief Commercial Officer | 2025-03-03 | Sale 10b5-1 | −200 | $323.65 | $64,730 | 9,667 | D |
| Huntsman Carole Chief Commercial Officer | 2025-03-03 | Sale 10b5-1 | −200 | $324.59 | $64,918 | 9,467 | D |
| Huntsman Carole Chief Commercial Officer | 2025-03-03 | Sale 10b5-1 | −100 | $326.34 | $32,634 | 9,367 | D |
| Huntsman Carole Chief Commercial Officer | 2025-03-03 | Sale 10b5-1 | −100 | $327.49 | $32,749 | 9,267 | D |
| Huntsman Carole Chief Commercial Officer | 2025-03-03 | Sale 10b5-1 | −100 | $329.64 | $32,964 | 9,167 | D |
| Huntsman Carole Chief Commercial Officer | 2025-03-03 | Sale 10b5-1 | −563 | $335.00 | $188,605 | 8,604 | D |
| Open-market sales · 1,834 sh · avg $325.98 · $597,840 | |||||||
Loading xslF345X05/wk-form4_1741209863.xml…